Phase 3 Hepatitis B Clinical Trials
8 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–8 of 8 trials
Recruiting
Phase 3
A Clinical Trial Evaluating the Safety of Hydronidone Capsules in Patients With Hepatic Fibrosis and Liver Cirrhosis
Chronic Hepatitis B With Hepatic Fibrosis
Beijing Continent Pharmaceutical Co, Ltd.300 enrolled1 locationNCT07343778
Recruiting
Phase 3
A Small Sample Prospective Clinical Study of Azvudine Tablets to Promote Clinical Cure in Patients With Chronic Hepatitis B
Chronic Hepatitis BAzvudine
Zhigang Ren120 enrolled1 locationNCT07307586
Recruiting
Phase 2Phase 3
A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series
DiphtheriaPoliomyelitisHepatitis B+3 more
LG Chem1,186 enrolled1 locationNCT06947499
Recruiting
Phase 3
A Study to Investigate the Safety and Efficacy of Undiluted Intravenous Infusion of I.V.-Hepabig Inj.
Hepatitis B
GC Biopharma Corp105 enrolled8 locationsNCT05686759
Recruiting
Phase 3
Clinical Study to Assess the Immunogenicity and Safety of Hexavalent Vaccine Containing Reduced Dose IPV
Diptheria ImmunizationTetanus ImmunizationPertussis Immunization+3 more
Serum Institute of India Pvt. Ltd.1,557 enrolled9 locationsNCT06413121
Completed
Phase 3Phase 4
Virological and clinical anti-HBV efficacy of tenofovir in antiretroviral naive patients with HIV/HBV co-infection
HIV Hepatitis B Coinfection
National Centre in HIV Epidemiology and Clincial Research51 enrolled1 locationACTRN12605000436673
Not Yet Recruiting
Phase 3
Tenofovir versus Adefovir for the treatment of HBeAg negative chronic hepatitis B
HBeAg negative Chronic Hepatitis B
Gilead Sciences Inc300 enrolled1 locationACTRN12605000029695
Not Yet Recruiting
Phase 3
Tenofovir versus Adefovir for the treatment of HBeAg positive chronic hepatitis B
HBeAg positive chronic hepatitis B
Gilead Sciences Inc240 enrolled1 locationACTRN12605000028606